Griet Boogaerts

1.8k total citations
7 papers, 184 citations indexed

About

Griet Boogaerts is a scholar working on Infectious Diseases, Hepatology and Virology. According to data from OpenAlex, Griet Boogaerts has authored 7 papers receiving a total of 184 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 3 papers in Hepatology and 2 papers in Virology. Recurrent topics in Griet Boogaerts's work include HIV/AIDS drug development and treatment (7 papers), Hepatitis C virus research (3 papers) and HIV Research and Treatment (2 papers). Griet Boogaerts is often cited by papers focused on HIV/AIDS drug development and treatment (7 papers), Hepatitis C virus research (3 papers) and HIV Research and Treatment (2 papers). Griet Boogaerts collaborates with scholars based in United States, Germany and United Kingdom. Griet Boogaerts's co-authors include Anton Pozniak, Brian Woodfall, Monika Peeters, Elena Vinogradova, Richard M. W. Hoetelmans, F. D. Goebel, Rolf van Heeswijk, Els De Paepe, Rodica Van Solingen‐Ristea and Maria Beumont and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Hepatology and AIDS.

In The Last Decade

Griet Boogaerts

7 papers receiving 170 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Griet Boogaerts United States	5	125	83	55	43	22	7	184
Hayley Farmer United States	6	83 0.7×	34 0.4×	44 0.8×	24 0.6×	21 1.0×	8	159
Anne-Marie Taburet France	5	185 1.5×	108 1.3×	60 1.1×	91 2.1×	32 1.5×	6	339
Leonie Swaden United Kingdom	8	256 2.0×	60 0.7×	23 0.4×	157 3.7×	17 0.8×	12	316
Rand R. Rhodes United States	4	112 0.9×	81 1.0×	17 0.3×	26 0.6×	14 0.6×	5	142
Megan Neary United Kingdom	10	196 1.6×	63 0.8×	19 0.3×	69 1.6×	18 0.8×	25	267
Claudia Fabrizio Italy	9	134 1.1×	51 0.6×	31 0.6×	102 2.4×	29 1.3×	17	218
Rita de Cássia Elias Estrela Brazil	10	159 1.3×	53 0.6×	19 0.3×	41 1.0×	42 1.9×	20	283
Stephen Walimbwa Uganda	6	156 1.2×	77 0.9×	10 0.2×	33 0.8×	20 0.9×	12	230
Anne Marie Taburet France	11	274 2.2×	206 2.5×	21 0.4×	72 1.7×	47 2.1×	20	419
Emma Hughes United States	10	143 1.1×	21 0.3×	18 0.3×	80 1.9×	66 3.0×	17	262

Countries citing papers authored by Griet Boogaerts

Since Specialization

Citations

This map shows the geographic impact of Griet Boogaerts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Griet Boogaerts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Griet Boogaerts more than expected).

Fields of papers citing papers by Griet Boogaerts

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Griet Boogaerts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Griet Boogaerts. The network helps show where Griet Boogaerts may publish in the future.

Co-authorship network of co-authors of Griet Boogaerts

This figure shows the co-authorship network connecting the top 25 collaborators of Griet Boogaerts. A scholar is included among the top collaborators of Griet Boogaerts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Griet Boogaerts. Griet Boogaerts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Heeswijk, Rolf van, Pieter Verboven, Jan Snoeys, et al.. (2013). Pharmacokinetic Interaction between Telaprevir and Methadone. Antimicrobial Agents and Chemotherapy. 57(5). 2304–2309. 22 indexed citations

2.

Boogaerts, Griet, et al.. (2012). Bioavailability of the HCV NS3/4A Protease Inhibitor Telaprevir–Effect of Different Types of Food. Zeitschrift für Gastroenterologie. 50(1). 1 indexed citations

3.

Boogaerts, Griet, et al.. (2011). Pharmakokinetik des Proteaseinhibitors Telaprevir bei schwerer Niereninsuffizienz. Zeitschrift für Gastroenterologie. 49(8). 1 indexed citations

4.

Heeswijk, Rolf van, Griet Boogaerts, Els De Paepe, et al.. (2011). 1245 THE EFFECT OF SEVERE RENAL IMPAIRMENT ON THE PHARMACOKINETICS OF THE INVESTIGATIONAL HCV PROTEASE INHIBITOR TELAPREVIR. Journal of Hepatology. 54. S492–S492. 12 indexed citations

5.

Heeswijk, Rolf van, Pieter Verboven, Griet Boogaerts, et al.. (2011). 1244 THE PHARMACOKINETIC INTERACTION BETWEEN METHADONE AND THE INVESTIGATIONAL HCV PROTEASE INHIBITOR TELAPREVIR. Journal of Hepatology. 54. S491–S492. 26 indexed citations

6.

Arastéh, Keikawus, Armin Rieger, Patrick Yéni, et al.. (2008). Short-term randomized proof-of-principle trial of TMC278 in patients with HIV type-1 who have previously failed antiretroviral therapy. Antiviral Therapy. 14(5). 713–722. 19 indexed citations

7.

Goebel, F. D., Anton Pozniak, Elena Vinogradova, et al.. (2006). Short-term antiviral activity of TMC278 – a novel NNRTI – in treatment-naive HIV-1-infected subjects. AIDS. 20(13). 1721–1726. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact